Literature DB >> 15558752

Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death.

Palwinder Mander1, Vilma Borutaite, Salvador Moncada, Guy C Brown.   

Abstract

Inflammatory-activated glia are seen in numerous central nervous system (CNS) pathologies and can kill nearby neurons through the release of cytotoxic mediators. Glia, when activated, can express the inducible isoform of nitric oxide synthase (iNOS) producing high levels of nitric oxide (NO), which can kill neurons in certain conditions. We show, however, that inflammatory activation of glia in a mature culture of cerebellar granule neurons and glia causes little or no neuronal death under normal (21%) oxygen conditions. Similarly, hypoxia (2% oxygen) or low levels of an NO donor (100 microM DETA/NO) caused little or no neuronal death in nonactivated cultures. If inflammatory activation of glia or addition of NO donor was combined with hypoxia, however, extensive neuronal death occurred. Death in both cases was prevented by the N-methyl-D-aspartate (NMDA) receptor blocker MK-801, implying that death was mediated by the glutamate receptor. Low levels of NO were found to increase the apparent K(M) of cellular oxygen consumption for oxygen, probably due to NO-induced inhibition of mitochondrial respiration, in competition with oxygen, at cytochrome oxidase. Necrotic death, induced by hypoxia plus DETA/NO, was increased further by deoxyglucose, an inhibitor of glycolysis, suggesting that necrosis was mediated by energy depletion. Hypoxia was found to be a potent stimulator of microglia proliferation, but this proliferation was not significant in inflammatory-activated cultures. These results suggest that low levels of NO can induce neuronal death under hypoxic conditions, mediated by glutamate after NO inhibition of respiration in competition with oxygen. Brain inflammation can thus sensitize to hypoxia-induced death, which may be important in pathologies such as stroke, neurodegeneration, and brain aging. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15558752     DOI: 10.1002/jnr.20285

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  26 in total

Review 1.  Nitric oxide and multiple sclerosis.

Authors:  Juan Manuel Encinas; Louis Manganas; Grigori Enikolopov
Journal:  Curr Neurol Neurosci Rep       Date:  2005-05       Impact factor: 5.081

2.  Assessing the physiological concentration and targets of nitric oxide in brain tissue.

Authors:  Catherine N Hall; David Attwell
Journal:  J Physiol       Date:  2008-06-05       Impact factor: 5.182

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Inflammatory neurodegeneration and mechanisms of microglial killing of neurons.

Authors:  Guy C Brown; Jonas J Neher
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

Review 5.  Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.

Authors:  Yong Gu; Jianping Chen; Jiangang Shen
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-22       Impact factor: 4.147

Review 6.  Intracranial hemorrhage: mechanisms of secondary brain injury.

Authors:  Josephine Lok; Wendy Leung; Sarah Murphy; William Butler; Natan Noviski; Eng H Lo
Journal:  Acta Neurochir Suppl       Date:  2011

7.  Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination.

Authors:  Kirsten S Evonuk; Brandi J Baker; Ryan E Doyle; Carson E Moseley; Christine M Sestero; Bryce P Johnston; Patrizia De Sarno; Andrew Tang; Igor Gembitsky; Sandra J Hewett; Casey T Weaver; Chander Raman; Tara M DeSilva
Journal:  J Immunol       Date:  2015-06-12       Impact factor: 5.422

Review 8.  The role of oxidative stress in Parkinson's disease.

Authors:  Vera Dias; Eunsung Junn; M Maral Mouradian
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

9.  Moringa oleifera modulates cholinergic and purinergic enzymes activity in BV-2 microglial cells.

Authors:  Stephen Adeniyi Adefegha; Charles Elias Assmann; Maria Rosa Chitolina Schetinger; Cinthia Melazzo de Andrade; Tatiana Emanuelli
Journal:  Metab Brain Dis       Date:  2021-01-04       Impact factor: 3.584

10.  The NO donor DETA-NONOate reversibly activates an inward current in neurones and is not mediated by the released nitric oxide.

Authors:  A J Thompson; P K Mander; G C Brown
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.